Hengruiyuan
About:
Hengruiyuan is a biopharmaceutical company that develops medications based on immune cell treatment technologies for solid tumors.
Website: http://www.shhryz.com
Top Investors: Goldport Capital, Zhongke Kechuang, Jiangsu Hengrui Medicine
Description:
Hengruiyuan is a biopharmaceutical company that develops medications based on immune cell treatment technologies for solid tumors.
Total Funding Amount:
300M CNY
Headquarters Location:
Songjiang, Shanghai, China
Founded Date:
2015-01-01
Contact Email:
hryz(AT)shhryz.com
Founders:
Number of Employees:
501-1000
Last Funding Date:
2024-01-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai